Arjo ABFRA:A39 +1.39%73 FCF Margin % is 8.78% as of Mar. 2026, which is 25% above its 10-year median of 7.02. GuruFocus rates FRA:A39 with a GF Score™ of 73/100 and a GF Value™ of €3.24 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 118 Medical Distribution companies, Arjo AB ranks better than 94.07% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Arjo AB's Free Cash Flow for the
three
months ended in Mar. 2026 was €22.0 Mil. Arjo AB's Revenue for the
three
months ended in Mar. 2026 was €250.5 Mil. Therefore, Arjo AB's FCF Margin % for the quarter that ended in Mar. 2026 was 8.78%.
The historical rank and industry rank for Arjo AB's FCF Margin % or its related term are showing as below:
FRA:A39'
s FCF Margin % Range Over the Past 10 Years
Min: -1.05 Med: 7.02 Max: 16.08
Current: 13.73
During the past 13 years, the highest FCF Margin % of Arjo AB was 16.08%. The lowest was -1.05%. And the median was 7.02%.
FRA:A39's FCF Margin % is ranked better than 94.07% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs FRA:A39: 13.73
Arjo AB FCF Margin % Related Terms
Arjo AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for Arjo AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arjo AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Arjo AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arjo AB (FRA:A39) has a FCF Margin % of 8.78% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Arjo AB and its competitors. This is 25% above median its historical median of 7.02. According to the industry distribution chart, Arjo AB ranks #7 out of 118 companies in the Medical Distribution industry, placing it in the top 5.9%.
Is Arjo AB's FCF Margin % too high?
Arjo AB's current FCF Margin % of 8.78% is 25% above median its 10-year median of 7.02. The Medical Distribution industry median FCF Margin % is 1.06. Arjo AB's value of 8.78% is 728.3% above this industry median. Based on the distribution chart, Arjo AB ranks #7 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Arjo AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arjo AB ranks #7 out of 118 companies for FCF Margin %. This places Arjo AB in the top 6% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 1.06. Arjo AB's value of 8.78% is 728.3% above this benchmark. While the company's 10-year median is 7.02 vs. the industry median of 1.06, Arjo AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arjo AB's current FCF Margin % of 8.78% is 728.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Arjo AB and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arjo AB's current FCF Margin % is 8.78%, which is 25% above median its own 10-year median of 7.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.24, compared to a current price of €2.19 — trading 32.5% below its estimated fair value. The current FCF Margin % is 8.78%, which is 25% above median its 10-year median of 7.02 and 728.3% above the Medical Distribution industry median of 1.06. Arjo AB's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current FCF Margin % is 8.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (FRA:A39) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of €2.19 is trading 32.5% below its estimated GF Value™ of €3.24.
GuruFocus considers Arjo AB to be Significantly Undervalued.
Key valuation signals for FRA:A39:
FCF Margin %: 8.78% (25% above median its 10-year median of 7.02)
GF Value™: €3.24 vs. price of €2.19 (32.5% below fair value)
Industry Position: 728.3% above the Medical Distribution median (#7 of 118)
No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
73GF Score
Get the complete analysis for FRA:A39
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A39 has been successfully added to your 
